Clicky

Guangdong Hybribio Biotech Co Ltd(300639)

Description: Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.


Keywords: Natural Sciences Biotechnology Molecular Biology Laboratory Techniques Biochemistry Polymerase Chain Reaction Hybridization Hearing Loss Amplifiers Human Papilloma Virus Real Time Polymerase Chain Reaction Thalassemia Sexually Transmitted Diseases Molecular Diagnostic Products Cell Free Fetal Dna

Home Page: www.hybribio.cn

50 Bonham Strand
Sheung Wan,
Hong Kong
Phone: 852 2851 8029


Officers

Name Title
Mr. Qiaozhong Guan GM & Director
Mr. Qinghui Li Fin. Director
Mr. Longxu Xie Deputy GM & Director
Mr. Zhisheng Guan Deputy GM & Non Independent Director
Ms. Jianyu Wang Exec. Deputy GM & Director
Mr. Yi Chen Deputy GM & Board Sec.
Xian Yuan Securities Representative
Ms. Danrong Weng Deputy Gen. Mang.

Exchange: SHE

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 4.5736
Price-to-Book MRQ: 1.729
Price-to-Sales TTM: 1.6255
IPO Date:
Fiscal Year End: December
Full Time Employees: 2356
Back to stocks